Alteogen

Alteogen Book Value per Share

The Book Value per Share of Alteogen (196170.KQ) as of Nov 12, 2026 is 8,316.77 KRW. In the previous year, Book Value per Share was 5,111.05 KRW — a change of 62.72% (higher).

Book Value per Share

8,316.77KRW

YoY

62.72%

Last updated:

Book Value per Share of Alteogen is 2025 8,316.77 KRW. Book Value per Share of Alteogen was 2024 5,111.05 KRW. It decreases by 62.72% higher compared to the previous year.

The Alteogen Book Value per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Book Value per Share
Date
Book Value per Share
Jan 1, 2018
1,244.65 KRW
Jan 1, 2019
1,307.36 KRW
Jan 1, 2020
2,450.30 KRW
Jan 1, 2021
2,554.33 KRW
Jan 1, 2022
2,779.00 KRW
Jan 1, 2023
2,766.95 KRW
Jan 1, 2024
5,111.05 KRW
Jan 1, 2025
8,316.77 KRW
The Alteogen Book Value per Share history
YEARBook Value per ShareYoY
8,316.77KRW+62.72%
5,111.05KRW+84.72%
2,766.95KRW-0.43%
2,779.00KRW+8.80%
2,554.33KRW+4.25%
2,450.30KRW+87.42%
1,307.36KRW+5.04%
1,244.65KRW+67.21%
744.35KRW-11.90%
844.93KRW+17.32%
720.18KRW+7.61%
669.25KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Alteogen Stock analysis

What does Alteogen do? Alteogen, Inc. generates revenue through its biobetter business segment, developing protein pharmaceuticals and cancer therapies, and its bio similar business segment, focusing on bio similar and animal medicines. The company sells growth hormone, herceptin, humira, antibodies, and other products primarily to healthcare providers and pharmaceutical distributors. Its biobetter segment targets oncology and protein-based treatments, while the bio similar segment serves both human and animal health markets with cost-effective alternatives to branded drugs. The firm's product portfolio includes growth hormone, herceptin, and humira, which are key revenue drivers in the biopharmaceutical sector. Herceptin and humira are well-established anticancer drugs, while growth hormone addresses endocrine disorders. The company's bio similar segment offers affordable versions of these therapies, appealing to budget-conscious healthcare systems and veterinary markets. Sales are concentrated in the human and animal medicine sectors, leveraging its dual focus on biobetter and bio similar products. Alteogen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Alteogen stock

Book Value per Share of Alteogen is 8,316.77 KRW in 2025.

Book Value per Share of Alteogen changed from 5,111.05 KRW to 8,316.77 KRW, representing a 62.72% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Book Value per Share Alteogen since 2006 – with annual values, charts, and detailed analysis.

Book value per share represents the net asset value of the company per outstanding share. Comparing it to the stock price helps assess whether a stock is undervalued.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Alteogen

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Alteogen